The responses, guidance, and advisories provided by the Pharmaceutical Advertising Advisory Board (PAAB),
including but not limited to those available through the PAAB Forum, the PAAB website, and any PAAB
correspondences, are specifically intended to assist individuals navigating the PAAB preclearance system.
Repurposing or reproducing this content without written consent from the PAAB Commissioner is strictly
prohibited. This prohibition includes, but is not limited to, use in machine learning or AI models.
404 - Hi Patrick, I am doing a slide kit for the reps based on our PM. In the PM it mentions a study with our drug against a non-approved drug, so I can use this info in my slide. New studies have come out on our drug vs the non-approved drug would I be able to use this new data in my slide deck for the reps.
-
Hi there. Use the following thought process to work through this scenario “The only reason the data is acceptable in spite of PAAB code 5.1 is that it appears in the PM”. As a deductive extension of this, other data from the same published study which is not found in the PM is not acceptable. As an additional extension, other similar data (e.g. from other studies) which is not in the PM are not acceptable.
